Development of bioactive solid-foam scaffolds from decellularized cartilage with chondrogenic and osteogenic properties.

Cartilage Collagen Decellularization Extracellular matrix

Journal

Materials today. Bio
ISSN: 2590-0064
Titre abrégé: Mater Today Bio
Pays: England
ID NLM: 101757228

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 11 06 2024
revised: 16 08 2024
accepted: 01 09 2024
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 19 9 2024
Statut: epublish

Résumé

Full osteochondral regeneration remains a major clinical challenge. Among other experimental cartilage regenerative approaches, decellularized cartilage (DCC) is considered a promising material for generating potentially implantable scaffolds useful as cartilage repair strategy. In this work, we focus on screening and comparing different decellularization methods, aiming to generate DCC potentially useful in biomedical context, and therefore, with biological activity and functional properties in terms of induction of differentiation and regeneration. Data indicates that enzymatic and detergents-based decellularization methods differentially affect ECM components, and that it has consequences in further biological behavior. SDS-treated DCC powder is not useful to be further processed in 2D or 3D structures, because these structures tend to rapidly solubilize, or disaggregate, in physiologic media conditions. Conversely, Trypsin-treated DCC powders can be processed to mechanically stable 2D films and 3D solid-foam scaffolds, presumably due to partial digestion of collagens during decellularization, which would ease crosslinking at DCC during solubilization and processing.

Identifiants

pubmed: 39296356
doi: 10.1016/j.mtbio.2024.101228
pii: S2590-0064(24)00289-8
pmc: PMC11408866
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101228

Informations de copyright

© 2024 The Authors. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Unai Mendibil (U)

Center for Cooperative Research in Biomaterials (CIC BiomaGUNE), Basque Research and Technology Alliance (BRTA), 20014, Donostia-San Sebastian, Spain.
TECNALIA, Basque Research and Technology Alliance (BRTA), 20009, Donostia-San Sebastian, Spain.

Yaiza Lópiz-Morales (Y)

Hospital Clínico San Carlos, 28040, Madrid, Spain.

Blanca Arnaiz (B)

Center for Cooperative Research in Biomaterials (CIC BiomaGUNE), Basque Research and Technology Alliance (BRTA), 20014, Donostia-San Sebastian, Spain.

Raquel Ruiz-Hernández (R)

Center for Cooperative Research in Biomaterials (CIC BiomaGUNE), Basque Research and Technology Alliance (BRTA), 20014, Donostia-San Sebastian, Spain.

Pablo Martín (P)

Center for Cooperative Research in Biomaterials (CIC BiomaGUNE), Basque Research and Technology Alliance (BRTA), 20014, Donostia-San Sebastian, Spain.

Desiré Di-Silvio (D)

Center for Cooperative Research in Biomaterials (CIC BiomaGUNE), Basque Research and Technology Alliance (BRTA), 20014, Donostia-San Sebastian, Spain.

Nerea Garcia-Urquia (N)

TECNALIA, Basque Research and Technology Alliance (BRTA), 20009, Donostia-San Sebastian, Spain.

Felix Elortza (F)

Proteomics Platform, Center for Cooperative Research in Biosciences (CIC BioGUNE), Basque Research and Technology Alliance (BRTA), CIBERehd, 48160, Derio, Spain.

Mikel Azkargorta (M)

Proteomics Platform, Center for Cooperative Research in Biosciences (CIC BioGUNE), Basque Research and Technology Alliance (BRTA), CIBERehd, 48160, Derio, Spain.

Beatriz Olalde (B)

TECNALIA, Basque Research and Technology Alliance (BRTA), 20009, Donostia-San Sebastian, Spain.

Ander Abarrategi (A)

Center for Cooperative Research in Biomaterials (CIC BiomaGUNE), Basque Research and Technology Alliance (BRTA), 20014, Donostia-San Sebastian, Spain.

Classifications MeSH